DEFINING THE CLINICAL UTILITY OF FLUORESCENCE IN-SITU HYBRIDIZATION (FISH) IN DETECTION OF 11Q23 REARRANGEMENTS IN HEMATOLOGICAL MALIGNANCIES - VALIDATION STUDIES OF THE MLL (11Q23) DNA-PROBE
Jl. Muratacollins et al., DEFINING THE CLINICAL UTILITY OF FLUORESCENCE IN-SITU HYBRIDIZATION (FISH) IN DETECTION OF 11Q23 REARRANGEMENTS IN HEMATOLOGICAL MALIGNANCIES - VALIDATION STUDIES OF THE MLL (11Q23) DNA-PROBE, American journal of human genetics, 61(4), 1997, pp. 409-409